Key facts
- MicroWash’s last known valuation is $4.6M (May 2023).
- It has raised $2.7M; the latest was Early Stage VC ($370K) in Aug 2025.
- Notable investors include Right Side Capital Management, Invest Nebraska, Bright Minds Capital Partners, MOVE Venture Capital, NMotion — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for MicroWash
- ·The full record, as it builds
Funding rounds
No funding rounds for MicroWash are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MicroWash
Developer of a nasal lavage specimen collection device designed for respiratory illness testing. The company features a device with a multi-year shelf life that provides sample sensitivity through a patented design, is simple and safe to use, integrates easily with existing lab processes, and aims to reduce patient discomfort, enabling healthcare providers and laboratories to obtain more reliable samples while facilitating increased testing rates and better infectious disease management.
- Sector
- Healthcare
- HQ
- Omaha, NE, United States
- Founded
- 2022
- Website
- getmicrowash.com/
- Ownership
- Privately Held (backing)
MicroWash doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MicroWash shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MicroWash in its N-PORT filings yet. We sweep new filings monthly.